In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
© 2021 Future Medicine Ltd..
Aim: SARS-CoV-2 caused more than 3.8 million deaths according to the WHO. In this urgent circumstance, we aimed at screening out potential inhibitors targeting the main protease of SARS-CoV-2. Materials & methods: An in-house carboline and quinoline database including carboline, quinoline and their derivatives was established. A virtual screening in carboline and quinoline database, 50 ns molecular dynamics simulations and molecular mechanics Poisson-Boltzmann surface area calculations were carried out. Results: The top 12 molecules were screened out preliminarily. The molecular mechanics Poisson-Boltzmann surface area ranking showed that p59_7m, p12_7e, p59_7k stood out with the lowest binding energies of -24.20, -17.98, -17.67 kcal/mol, respectively. Conclusion: The study provides powerful in silico results that indicate the selected molecules are valuable for further evaluation as SARS-CoV-2 main protease inhibitors.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - year:2021 |
---|---|
Enthalten in: |
Future virology - (2021) vom: 01. Juli |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Muhtar, Eldar [VerfasserIn] |
---|
Links: |
---|
Themen: |
Carboline |
---|
Anmerkungen: |
Date Revised 27.07.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.2217/fvl-2021-0099 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM328509876 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM328509876 | ||
003 | DE-627 | ||
005 | 20231225203055.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2217/fvl-2021-0099 |2 doi | |
028 | 5 | 2 | |a pubmed24n1094.xml |
035 | |a (DE-627)NLM328509876 | ||
035 | |a (NLM)34306166 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Muhtar, Eldar |e verfasserin |4 aut | |
245 | 1 | 0 | |a In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 27.07.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2021 Future Medicine Ltd. | ||
520 | |a Aim: SARS-CoV-2 caused more than 3.8 million deaths according to the WHO. In this urgent circumstance, we aimed at screening out potential inhibitors targeting the main protease of SARS-CoV-2. Materials & methods: An in-house carboline and quinoline database including carboline, quinoline and their derivatives was established. A virtual screening in carboline and quinoline database, 50 ns molecular dynamics simulations and molecular mechanics Poisson-Boltzmann surface area calculations were carried out. Results: The top 12 molecules were screened out preliminarily. The molecular mechanics Poisson-Boltzmann surface area ranking showed that p59_7m, p12_7e, p59_7k stood out with the lowest binding energies of -24.20, -17.98, -17.67 kcal/mol, respectively. Conclusion: The study provides powerful in silico results that indicate the selected molecules are valuable for further evaluation as SARS-CoV-2 main protease inhibitors | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a MD simulation | |
650 | 4 | |a MM-PBSA | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a carboline | |
650 | 4 | |a dPCA | |
650 | 4 | |a main protease | |
650 | 4 | |a virtual screening | |
700 | 1 | |a Wang, Mengyang |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Haimei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Future virology |d 2006 |g (2021) vom: 01. Juli |w (DE-627)NLM182701131 |x 1746-0794 |7 nnns |
773 | 1 | 8 | |g year:2021 |g day:01 |g month:07 |
856 | 4 | 0 | |u http://dx.doi.org/10.2217/fvl-2021-0099 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2021 |b 01 |c 07 |